At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

The researchers have conducted a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique aimed at ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

The Patent Trial and Appeal Board was ordered to review a claim by a UC Berkeley team that gene-editing technology originated in their studies and not with the Broad Institute of Harvard and MIT. Also ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

The country's third most valuable company by market cap is a study in contrasts. It's a wealth-altering 13-bagger over the ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics ... presentation anticipated at a medical meeting in the second ...